Replies to post #28461 on Ayala Pharmaceuticals Inc (ADXS)

[dafreaks]

The problem I have is that these weak PR's simply let everyone that nothing has changed, status quo, more of the same.

[ignatiusrielly35]

Ridiculous. First of all, ADXS must report when they are presenting clinical data at a conference. It's basic investor relations. They are not reporting it for some type of hype. It's called keeping shareholders and the public informed. Second, the ADXS/Merck prostate trial results are very important, and you can bet that analysts and BPs will be interested in the data. The data also could very well be a precursor to a licensing deal with Merck or even a potential buyout. Obviously, Merck already knows the data.

[zzaatt]

Boilerplate garbage!!!!

Can anyone find anything relevant to ADXS in this:

Yes, I do have an issue with it. I'll be the first to say I'm here for returns, not for medicine. If the medicine is great and helps people, that's really, really great and I'm happy to have taken part. But let's not kid ourselves -- we could go down to a charity and donate our money if that's what we wanted to do.

They've been touting these conferences for years and it's been a non-event. Every. Single. Time. Enough is enough. Try something new. ANYTHING.

And I'm not even factoring in that the past few conferences in particular have been exceptionally underwhelming as far as new substance.

All CRAP!!!!